In Japan, the morbidity rate for pertussis per 100,000 population was 147.6 in 1950 when whole cell pertussis vaccine was introduced but dropped to 0.2 in 1972 when routine immunization with a combined vaccine consisting of diphtheria toxoid, tetanus toxoid, and whole cell pertussis had been widely accepted. Thereafter, adverse reactions to the whole cell pertussis vaccine became a social problem and lowered the acceptance of the vaccine. As a result, the morbidity rate increased to 11.3 in 1979. Introduction of the safer yet efficacious acellular pertussis vaccine, consisting of mainly pertussis toxoid and filamentous hemagglutinin, into the routine childhood vaccination in combination with diphtheria and tetanus toxoids in 1981 increased the acceptance rate. The lowest morbidity rate, 0.1, was achieved in 1993. During the next 16 years, almost all cases were in unvaccinated or incompletely vaccinated persons. Regardless of whether whole cell or acellular pertussis vaccine was used, ú90% of the reported pertussis cases were in children õ10 years of age until 1990. However, since 1991, the rate of pertussis in young adults 20 -44 years of age has been clearly increasing. To control pertussis, booster vaccination with diptheria toxoid -tetanus toxoidacellular pertussis vaccine in adults should be considered.
Pertussis, diphtheria, and tetanus are serious infectious disfurther, down to almost 10% in 1976 [2] . Consequently, the number of pertussis cases increased dramatically: The morbideases whose symptoms are mediated by bacterial toxins and are typical vaccine-preventable diseases. In Japan, diphtheria ity rate per 100,000 population increased from 0.4 in 1974 to 11.3 in 1979 [3] . Thus, introduction of a new, safer yet efficatoxoid, whole cell pertussis vaccine (wP), diphtheria-pertussis combined vaccines, and tetanus toxoid were introduced in cious pertussis vaccine became an urgent social demand in Japan. At the same time, since diphtheria and tetanus toxoids 1948, 1949, 1958, and 1960 , respectively. Diphtheria toxoidtetanus toxoid -wP combined vaccine (DTwP) was officially vaccine (DT) was widely accepted, the incidence of diphtheria and tetanus decreased continuously. incorporated into the routine vaccination schedule for childhood in 1968 [1] .
We developed an acellular pertussis vaccine (aP) consisting mainly of two protein antigens, pertussis toxoid and filamenSince pertussis and diphtheria are contagious respiratory diseases, widespread use of DTwP resulted in herd immunity in tous hemagglutinin (FHA), and this new diphtheria toxoidtetanus toxoid -acellular pertussis combined vaccine (DTaP) children and a rapid decrease in cases of these two diseases, as shown in figure 1 . However, wP-containing vaccines had was introduced in 1981 in place of DTwP for the routine vaccination of children at age 2 years [4, 5] . Soon after the introducbeen accepted reluctantly from the beginning because of a high frequency of local and systemic adverse reactions to the wP tion of the DTaP vaccine, the acceptance rates increased to ú80% in 1982 because of much less adverse reactions [2, 5] . in spite of its significant protective efficacy against pertussis. Just at the time when pertussis was becoming a rare disease Cases of pertussis decreased rapidly, again as shown in figure  1 . The Ministry of Health and Welfare, after 7 years of safe (the morbidity rate per 100,000 population calculated from the reported cases of clinical disease was 0.2 -0.3 during 1971 -and effective use of DTaP, recommended its use for vaccination of infants 3 months of age at a mass immunization in 1988 1973), two fatal accidents following DTwP vaccination in 1974 and 1975 were widely publicized. These two fatalities and the [2] . The number of pertussis cases reached the lowest record, 130, in 1993. During the 16 years following its introduction, adverse reactions associated with DTwP caused considerable concern among parents and pediatricians and became a social ú60 million doses of this DTaP vaccine have been administered to Japanese children, who have been almost completely problem. After temporary suspension of pertussis vaccination for 2 months in 1975 to consider a countermeasure for this protected from these three diseases. Almost all cases of these diseases in Japan were in unvaccinated or incompletely vaccisituation, the initial vaccination age for DTwP was raised from 3 months to 2 years. However, acceptance of DTwP decreased nated persons [3, 6, 7] . S125 CID 1999; 28 (Suppl 2) Pertussis in Adults lent aP vaccine is produced at all [1, 3, 8, 9] . Thus, most people are not vaccinated, even with either diphtheria toxoid or tetanus toxoid, after 12 years of age except under special circumstances, such as injury or travel to a country with diphtheria. Figure 2 shows the age distribution of annual reported cases of pertussis from 1959 to 1995. Routine vaccination of infants with DTwP kept the incidence of pertussis at low levels from 1968 until 1974. After the fatalities with DTwP, there was a recurrence of pertussis. However, routine vaccination with the new DTaP, even at age 2 years, lowered the incidence again.
Diphtheria, Tetanus, and Pertussis Immunization Schedule

Age Distribution of Pertussis Cases
The age distribution of the reported pertussis cases is shown in figure 3 . Regardless of whether it was the DTwP or DTaP era, ú90% of the reported cases were in children õ10 years of age until 1990. However, after 1991, the rate of pertussis in those ú10 years of age increased significantly. Figure 4 shows the age-specific proportion of total pertussis cases in 1971, 1981, 1991, and 1995. The rate in young adults 20 -44 years of age is clearly increasing in 1991 and 1995. Figure 5 shows the age-specific proportion of reported pertussis cases in young adults 20 -44 years old. The numbers of annual reported cases in this age group are almost the same in 1959 -1967 and in 1991 -1995, but the rates in young adults reached 7% -11% for the last 5 years (1991 -1995) compared with õ1% during 1959 -1967. These young adults were born before 1975, when DTwP was used. Those who were born between 1967 and 1975, when the incidence of pertussis was the lowest in the DTwP era and the vaccination rates were also low (13% -57%), had less chance to be immunized with either natural infection or vaccination. It is possible that the majority of these patients were unvaccinated but had been protected by Ç30,000 doses of diphtheria toxoid for adults are manufactured * A fourth dose is given 12 -18 months after dose 3. Children receive a booster injection of diphtheria and tetanus toxoids at 11 -12 years of age. vaccination. Almost all patients with pertussis are unvaccinated the introduction of the tetanus toxoid are unvaccinated, because adults are not routinely vaccinated in Japan. with DTaP.
Age Distribution of Diphtheria Cases
Seroepidemiology of Pertussis, Diphtheria, and Tetanus The reported number of cases of diphtheria has been decreasData regarding antibody levels to pertussis antigens in a ing rapidly since introduction of the diphtheria toxoid (figures wide age group are very limited. A correlation between anti-1 and 6). Before 1980, ú40% of the patients were children toxin levels and age is difficult to establish: ú50% of almost õ10 years old. In the 10-year period 1986 -1995, õ10 cases all age groups had antibody to pertussis toxin of ú10 ELISA were reported annually, most of which were sporadic, but small units/mL in 1985. Among them, the young adults (18 -40 years outbreaks had also occurred. However, the numbers of recent of age) had slightly lower levels of antibody to pertussis toxin cases are too small to permit conclusions regarding an age and FHA. The highest titer of antibodies to pertussis toxin was tendency.
õ50 ELISA units/mL in young adults, compared with ú200 ELISA units/mL in both younger and older age groups. AntiAge Distribution of Tetanus Cases body titers in children and older adults are more widely scattered, from undetectable levels to ú100 units/mL [10] . Recent Tetanus decreased gradually but continuously from 1960, data also showed a similar tendency of levels of antibody to when the tetanus toxoid was introduced, until 1980. However, pertussis toxin that is waning in young adults (data not shown). a small but constant number of cases has been reported every A recent serological survey of levels of antibody to diphtheyear since 1980 (figures 1 and 7). More than 80% of patients ria toxin in Japan showed that half of the adults 30 -50 years in recent years are adults aged ú40. Since tetanus is not a of age had less than the protective level of antitoxin (õ0.01 contagious disease, people cannot benefit from herd immunity.
neutralizing unit/mL); ú80% of younger (õ30 years) and older Immunity to tetanus must be acquired individually by vaccina-(ú50 years) age groups had antitoxin levels of ú0.01 neutraliztion with tetanus toxoid, since it is not acquired by infection. Almost all of the adults ú40 years old who were born before ing unit/mL, although the young age group had higher antitoxin / 9c69$$ju10 05-12-99 11:41:24 cida UC: CID tion schedule to only children. Because many young adults, titers than did the older group [11a]. The young age group such as parents, nurses, or schoolteachers, have more opportumust have acquired the antitoxin from vaccination, but adults nities for contact with infants and young children, they must ú50 years of age, who were born in the prevaccine era, may become a major reservoir for transmission to nonimmunized maintain the protective level of antitoxin by additional subcliniinfants and children if they are infected with pertussis. To cal or nonsymptomatic infection. Although it seems that toxicontrol pertussis more effectively (as well as diphtheria), vaccigenic diphtheria strains have almost disappeared from the popnation of adults, especially these young adults, with DTaP ulation in Japan, this may not be true. To understand the should be important. immunologic and microbiological situation in Japan, a more According to Swedish reports on adverse reactions in adults precise survey must be necessary. However, to prevent disease to the Japanese acellular pertussis vaccines JNIH 6 (pertussis in adults as well as in children, the importance of vaccination toxoid plus FHA) and JNIH 7 (pertussis toxoid) [13, 14] , the of adults must be emphasized [12] . adverse reactions to both acellular pertussis vaccines were Unlike the situation with pertussis and diphtheria, in the case much less than those elicited by whole cell vaccines in adults, of tetanus, a correlation between incidence and antitoxin levels and JNIH 7 had a lower rate of reactions than did JNIH 6. is clear. Almost all of the adults ú40 years old have no detect-A comparative survey shows the incidence of serious adverse able antibody to tetanus [9, 11] .
reactions, such as encephalopathy, convulsions, and sudden death, to DTwP and DTaP in Japan [15] . From 1970 to 1974, Discussion and Summary when DTwP was given to infants 3 months of age, the incidence of serious adverse reactions was 3.4 per million doses. From The seroepidemiological situation of diphtheria and pertussis 1975 to 1980, when DTwP was given to infants §2 years old, in Japan is similar. The existence of significant antitoxin levels the rate was 1.1 per million doses. From 1981 to 1989, when in older persons suggests that the pertussis and diphtheria DTaP was administered to infants §2 years and to some infants pathogens are still widespread in the Japanese population and 3 months of age, the rate dropped to 0.24 per million doses. cause mild respiratory symptoms in persons with waning imAlthough the data on DTaP were limited to 30 million doses munity and give a natural booster to adults. However, the of vaccine during 1981 -1998, it is evident that the incidence numbers of adults lacking antigenic stimuli from vaccination of such severe reactions became lower with the DTaP vaccine or from natural exposure will be increasing. Adults who were [1, 2, 15] . not vaccinated or vaccinated ú10 years ago might be susceptiThe U.S. Food and Drug Administration approved two types ble to infection with pathogenic Bordetella pertussis and Coryof aP vaccine manufactured by two Japanese companies in nebacterium diphtheriae.
1991, and the DTaP vaccine in the United States has been The recent significant increase of pertussis in young adults must be warning against limiting the recent pertussis vaccinaadministered in children since then [16] .
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